AUTOIMMUNE CYTOPENIA
Clinical trials for AUTOIMMUNE CYTOPENIA explained in plain language.
Never miss a new study
Get alerted when new AUTOIMMUNE CYTOPENIA trials appear
Sign up with your email to follow new studies for AUTOIMMUNE CYTOPENIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New antibody drug offers hope for stubborn blood disorders
Disease control Recruiting nowThis study tests a new drug called CM336 in people with autoimmune cytopenia, a condition where the immune system attacks blood cells. The drug aims to control the disease by targeting certain immune cells. About 158 adults with relapsed or refractory forms of immune thrombocytop…
Matched conditions: AUTOIMMUNE CYTOPENIA
Phase: PHASE1, PHASE2 • Sponsor: Keymed Biosciences Co.Ltd • Aim: Disease control
Last updated May 26, 2026 06:44 UTC
-
New study aims to crack the code of autoimmune diseases
Knowledge-focused Recruiting nowThis study is creating a tool to help doctors diagnose and choose treatments for autoimmune diseases. Researchers will analyze blood and other samples from 500 children with autoimmune conditions and healthy children to find patterns in genes and proteins. The goal is to better u…
Matched conditions: AUTOIMMUNE CYTOPENIA
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated May 20, 2026 11:54 UTC